Tibet Duo Rui Pharmaceutical Co.,Ltd. (SZSE:301075) agreed to acquire 51% stake in Hongxi Medical Technology (Tianjin) Co., Ltd. from Li Zhanbing, Tian Bin, Zhang Hengrui and Xiong Rongliang for CNY 0 on January 17, 2024. As of October 31, 2023, Hongxi Medical Technology (Tianjin) Co., Ltd. generated total assets of CNY 0.28 million and net assets of
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.9 CNY | -0.44% |
|
-1.30% | -40.38% |
1st Jan change | Capi. | |
---|---|---|
-40.38% | 17Cr | |
+55.32% | 82TCr | |
+44.05% | 64TCr | |
-6.75% | 35TCr | |
+13.56% | 31TCr | |
+10.68% | 30TCr | |
+16.57% | 24TCr | |
+13.31% | 22TCr | |
+8.48% | 17TCr | |
-2.81% | 16TCr |
- Stock Market
- Equities
- 301075 Stock
- News Tibet Duo Rui Pharmaceutical Co., Ltd.
- Tibet Duo Rui Pharmaceutical Co.,Ltd. agreed to acquire 51% stake in Hongxi Medical Technology Co., Ltd. for CNY 0.